Thermo Fisher Partners with HealthVerity to Enhance Clinical Research Data

Thermo Fisher Scientific's PPD clinical research business has announced a strategic collaboration with HealthVerity to leverage real-world patient data. Through this partnership, Thermo Fisher will gain access to the TaXOnomy claims dataset, which represents more than 270 million de-identified patients. The collaboration aims to significantly enhance clinical development and evidence generation capabilities for biopharma sponsors. By integrating massive real-world datasets into clinical trial processes, the initiative seeks to improve data-driven decision-making across the pharmaceutical industry. This move strengthens Thermo Fisher's value proposition in the clinical research market by offering more comprehensive analytical services. Analysts suggest this partnership could drive increased service demand for TMO by providing more robust evidence for drug development.